ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTER01

New methods to measure and interrupt metabolic fluxes in brain cancer

Active
Institution
UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
Principal investigator
Daniel R Wahl
Funding
$2.8M
Duration
2025–2029
Open portfolio

Moonbase score

Still being scored

Abstract

ABSTRACT Glioblastomas (GBMs) are deadly incurable brain cancers that are treated with resection followed by radiation, which is often combined with chemotherapy. GBMs rewire their metabolism to fuel their growth, invasion, survival and treatment resistance. Therapeutic strategies to block altered GBM metabolism are being translated into the clinic, however we do not know which metabolic strategy is optimal for the treatment of GBM patients. Further, we lack methods to directly measure metabolic activity in human brain cancers, which makes it difficult to determine which patients are likely to respond to which metabolic treatment strategy. In this research proposal, we will develop new methods to directly measure metabolic pathway activity in mouse models and patients with GBM. We will then perform a therapeutic clinical trial to evaluate the safety, on-target activity, and potential efficacy of a new metabolic strategy for the treatment of GBM.

Research team

  • Deepak NagrathPI
  • Daniel R WahlPI

LOADING MOONBASE SCORE

R01NATIONAL CANCER INSTITUTESpecial Emphasis Panel[ZRG1 BTC-D (02)]measuremetabolicdirectly measuremetabolic pathwaynew methodsmetabolic activitygbmgbm patients

Questions for UNIVERSITY OF MICHIGAN AT ANN ARBOR

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.